Jeffrey Tate - Feb 28, 2022 Form 4 Insider Report for Cyclo Therapeutics, Inc. (CYTH)

Role
Chief Operating Officer, Director
Signature
/s/ Jeffrey Tate
Stock symbol
CYTH
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 03:32 PM
Previous filing
Aug 30, 2021
Next filing
Apr 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTH Stock Options (Right to buy) Award $0 +31.1K $0.00 31.1K Feb 28, 2022 Common Stock 31.1K $3.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a four year period in equal monthly installments.